Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

METHYLPREDNISOLONE for Rheumatoid arthritis: Side Effects & Safety Data

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

There are 1,298 adverse event reports in the FDA FAERS database where METHYLPREDNISOLONE was used for Rheumatoid arthritis.

Most Reported Side Effects for METHYLPREDNISOLONE

Side Effect Reports % Deaths Hosp.
Off label use 10,364 16.2% 2,842 4,839
Drug ineffective 9,959 15.6% 2,776 4,831
Product use in unapproved indication 4,115 6.4% 1,482 1,619
Condition aggravated 3,784 5.9% 1,548 2,136
Headache 3,419 5.4% 1,128 1,653
Fatigue 3,250 5.1% 1,192 1,622
Pyrexia 3,226 5.1% 998 2,014
Pain 3,165 5.0% 1,348 1,532
Nausea 3,105 4.9% 989 1,793
Pneumonia 3,006 4.7% 1,598 1,933
Rash 3,005 4.7% 1,367 1,511
Hypertension 2,801 4.4% 1,372 1,378
Diarrhoea 2,684 4.2% 1,199 1,648
Dyspnoea 2,592 4.1% 942 1,568
Rheumatoid arthritis 2,381 3.7% 1,301 1,227

Other Indications for METHYLPREDNISOLONE

Product used for unknown indication (9,568) Immunosuppressant drug therapy (5,162) Premedication (2,339) Immunosuppression (2,041) Covid-19 (1,633) Prophylaxis against transplant rejection (1,274) Systemic lupus erythematosus (1,135) Renal transplant (1,090) Acute lymphocytic leukaemia (1,022) Transplant rejection (968)

Other Drugs Used for Rheumatoid arthritis

ETANERCEPT (186,585) ADALIMUMAB (154,287) METHOTREXATE (84,654) TOFACITINIB (77,765) ABATACEPT (75,236) TOCILIZUMAB (55,449) CERTOLIZUMAB PEGOL (47,602) RITUXIMAB (40,017) UPADACITINIB (33,555) GOLIMUMAB (31,947)

Related Pages

METHYLPREDNISOLONE Full Profile All Rheumatoid arthritis Drugs METHYLPREDNISOLONE Demographics METHYLPREDNISOLONE Timeline